and those of Sim and McCraw is probably due to factors such as individual subject variation or differing experimental conditions. The most surprising finding in the aggregation studies was the inhibition of ristocetin-induced aggregation during the sustained dosing study in case 1. Lack of aggregation to ristocetin is characteristically associated with von Willebrand's disease, in which there is evidence of defective adhesion of platelets to subendothelium'7 and, in pigs, resistance to experimentally induced atherosclerosis." Inhibition of ristocetin-induced aggregation therefore suggests that DHLA may have an inhibitory effect on platelet-vessel wall interaction, a probable early event in the formation of arterial thrombi. No other features of von Willebrand's disease were detected.
Diets low in saturated fats and rich in polyunsaturated fats (predominantly linoleic acid) both lower heparin-neutralising activity1 and reduce platelet aggregability. 2 Since linoleic acid is a precursor of DHLA (fig 1) both these effects may be mediated through its conversion to DHLA. Such diets have also been reported to reduce mortality due to atherosclerosis,21 and partial substitution of dietary saturated fats by polyunsaturated fats has been widely recommended as a means of reducing the risk of coronary heart disease.22 23 Perhaps small doses of DHLA may be equally if not more effective than major dietary manipulations in preventing and treating these conditions. MVcedicalo7urn-al, 1977, 1, 867. (Accepted 21 Septcmber 1977) Reticulocytopenia and "absence" of red cell autoantibodies in immune haemolytic anaemia U M HEGDE, E C GORDON-SMITH, SHEILA M WORLLEDGE Briti'sli Medical :your ial, 1977 , 2, 1444 -1447 Summary A raised reticulocyte count is common in patients with immune or autoimmune haemolytic anaemia, and the result of the direct antiglobulin test (DAGT) is usually positive because of IgG or IgG and complement components on the red cells. We report on three patients who had low reticulocyte counts when they were most anaemic, and in whom no red cell autoantibodies could be detected by the DAGT. We postulate that reticulocytes may be selectively destroyed if antibodies are directed against antigenic sites on these young red cells, thus giving rise to a population of cells whose antigenic sites are poorly expressed. This theory might explain the low reticulocyte counts Introduction Increased destruction of red cells in "warm" immune or autoimmune haemolytic anaemia (AIHA) is commonly associated with a positive direct antiglobulin test (DAGT) result, usually because of the presence of either IgG alone or IgG and complement on the surface of the red cells. Some patients have all the clinical features of AIHA, but no antibody can be detected on the red cells by the direct antiglobulin test.1'-:' By using the sensitive antiglobulin consumption technique, however, small quantities of antibody belonging to the IgG class have been shown on the red cells of some patients with a negative DAGT result.' Most patients with AIHA have a raised reticulocyte count at presentation-a reflection of the high erythroid turnover that occurs to compensate for the anaemia and anoxaemia.
Crosby and Rappaport,5 however, noted the occurrence of reticulocytopenia in AIHA, and Pirofsky:3 also reported a low reticulocyte count in some patients with this disorder whose bone-marrow aspirate was normal or hyperplastic.
We report on three patients who had haemolytic anaemia with some unusual features. Neither IgG antibodies nor complement components could be shown on the red cells in one of these patients, and only complement components were found in the other two. All three patients had a low reticulocyte count when they were most anaemic. We used radioisotope studies to investigate the rate and sites of red cell destruction. Haematological methods used are those described by Dacie and Lewis.6 Case reports CASE 1 The patient was 9 years old when she first presented in December 1975 with a short history of jaundice (see fig 1) . She was pale and jaundiced, and had no lI mphadenopathv or hepatosplenomegaly. JOURNAL 3 DECEMBER 1977 moglobinuria (PCH), and drug-induced anaemias were all excluded in the patients reported here. Despite the failure of the DAGT to show antibody on the red cells of these patients the mechanism of accelerated red cell destruction was probably immune. The demonstration by Gilliland et al' of small but abnormal amounts of IgG antibody on the red cells of patients with Coombs-negative AIHA shows that active haemolysis may occur with concentrations of antibody well below the lower limit of sensitivity of the conventional antiglobulin test. Furthermore, these workers7 found abnormal amounts of IgG antibody by use of the antiglobulin consumption technique in 13 of 16 patients in whom only complement components were detected by the DAGT. They concluded that in many patients with AIHA in whom the DAGT shows only cell-bound complement, this fixation of complement had been mediated in vivo by trace amounts of IgG red cell autoantibody. The clinical course of our patients was similar to that commonly seen in AIHA. Although the third patient did not remain in remission after splenectomy, or even while on relatively high doses of steroids, he did respond to the immunosuppressive agent azathioprine on two occasions, and indeed relapsed when this drug was withdrawn. The second patient developed neutropenia, thrombocytopenia, and reticulocytopenia simultaneously while in relapse. The association of neutropenia with AIHA is uncommon, unlike that of thrombocytopenia. ' Nevertheless, pancytopenia in AIHA has been noticed by other workers,' and it has been suggested:' that single or multiple antibody formation may result in concurrent thrombocytopenia, neutropenia, or even pancytopenia in patients with AIHA. Erythrophagocytosis, often seen in AIHA, was conspicuous in the bonemarrow aspirates in patients 1 and 3, and this may well have followed coating of red cells by trace amounts of IgG.'2 " The remission after splenectomy in the first patient reflects the high sensitivity of the spleen to relatively low-density proteincoating in mediating red cell destruction.
The bone marrow is invariably hyperplastic to compensate for the shortened red-cell lifespan in AIHA. It is therefore remarkable that our patients had low reticulocyte counts at presentation, when their bone marrow showed normal or even increased numbers of erythroid precursors. Pirofsky3 suggested that in AIHA associated with other diseases such as lymphoma the bone marrow's capacity to increase under stress was limited.
No underlying disease, however, was found in our patients. The failure to detect antibody and the reticulocytopenia is difficult to explain. Auto-antibodies Conventionally, '5Cr has been used to study red cell survival in AIHA, and surface counting over the spleen and liver often gives information on the rate and sites of red-cell destruction.
Ideally, only the patient's own cells should be labelled. This is often impossible in patients who haemolyse at an extremely high rate and who require repeated blood transfusions. Also, as discussed above, cells which are heavily coated with autoantibody will be selectively and rapidly destroyed, leading to an accumulation of cells for which the antibody has low affinity. 5ICr studies using the patient's own cells may therefore measure the survival of this longer-lived population. Our out to determine whether it was possible to continue safely beyond 550 mg/rm2 with the use of cardiac glycosides.
Patients and methods
One of us (DG) has treated many patients with cytotoxic regimens that have included doxorubicin. Among these were 29 who had a total dose of doxorubicin of over 400 mg. These patients all had advanced gynaecological cancer and fell into three groups on the basis of their cardiac glycoside therapy: six patients had no cardiac glycoside; six were given ouabain 0 25 mg intravenously 15 minutes before each dose of doxorubicin; and 17 were given digoxin 0 25 mg day starting seven days before the first dose of doxorubicin and continuing until four weeks after the cessation of all cytotoxic treatment. The dose of digoxin was reduced only when electrocardiograms (ECGs) showed evidence of digoxin toxicity.
All patients had an ECG recorded before treatment and every three or four weeks after a total dose of 400 mg doxorubicin had been reached. All ECGs were read blind by one of us (ALG) who knew only that a patient was receiving a cardiac glycoside but not which one. All three groups of patients were comparable as regards age (mean 54 years), blood pressure, and other factors concerning the cardiovascular system. There were no diabetic patients in the series, and no patient had any history of coronary artery disease.
Results
Minor ECG changes were noted in five of the six patients who were not taking cardiac glycosides and four of the six patients taking ouabain. The only changes noted in the digoxin group were those relating to the digoxin itself, except in one patient who stopped taking her digoxin and later developed cardiomyopathy. One other patient, who was taking ouabain, also developed cardiomyopathy. The case histories of these two patients are given below.
Statistical analysis comparing those receiving digoxin with those receiving other treatment, using a Z2 test with Yates's correction for continuity,< showed a highly significant difference (P<0 001). The patient who took herself off digoxin was omitted for the purposes of statistical analysis.
In the group not receiving cardiac glycosides doxorubicin treatment was stopped at 550 mg/M2. Two of the patients receiving ouabain had over 500 mg/M2 of doxorubicin: one had 600 mg/M2 and the other, who developed cardiomyopathy, had 1000 mg/M2.
